With a market capitalization of approximately $13.3 billion, Align Technology, Inc. (ALGN) has established itself as one of ...

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® system of clear aligners, iTero™ ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Align Technology (NASDAQ:ALGN) ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...

The European Commission announced the opening of a formal antitrust investigation into Align Technology (Nasdaq:ALGN).

Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the ...

New professional marketing initiative celebrates the role doctors play in digital orthodontics and provides a platform to inspire others through their personal stories. Initiative underscores Align’s ...

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These ...

Align Technology, Inc. (NASDAQ:ALGN) released its first-quarter results after Wednesday's closing bell. Here's a look at the details from the quarter. The Details: Align Technology reported quarterly ...

Align Technology, Inc. (NASDAQ:ALGN) shares are trading higher by 3% to $223.00 Friday morning after the company announced plans to repurchase $275 million of its common stock as part of a $1 billion ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Align Tech. Looking at options history for Align Tech (NASDAQ:ALGN) we detected 8 trades. If we consider the specifics of ...

The quarter wasn't quite as good as that sounds. Align beat on sales and exceeded its own expectations. Still, sales grew less than 2% year over year, and they declined sequentially -- and it seems ...